Because HB is very rare, and nearly all children with HB receive neoadjuvant chemotherapy prior to tumor resection, we were unable to obtain matched pre- and post-treatment patient tumor samples to directly determine treatment-induced changes in RRM2 and RRM2B expression. The gene discussed is RRM2; the disease is neoplasm.